Aurobindo Pharma Limited

Quant Mutual Fund reduced its stake in Aurobindo Pharma by selling 371,210 shares, decreasing its holding from 28,869,269 shares to 28,498,059 shares. The shares were valued at approximately ₹56.96 crore based on the share price of ₹1532.00. Quant Mutual Fund participated in Aurobindo Pharma's buyback, tendering shares at ₹1,475 per share.

A major manufacturer of active pharmaceutical ingredients and generic pharmaceuticals, Aurobindo Pharma produces a diverse range of pharmaceutical products serving domestic and international markets. The company operates across multiple therapeutic segments and maintains manufacturing facilities that comply with global quality standards. Its vertically integrated operations, coupled with significant research and development capabilities, distinguish it as a key player in India's pharmaceutical sector.

Built a quantitative, data-driven investment philosophy in an industry dominated by discretionary stock pickers. Manages over Rs 1.2 lakh crore. Founded by Sanjeev Sharma, Quant MF uses VLRT (Valuation, Liquidity, Risk, and Time) framework to run high-turnover, tactically active portfolios. Grew from obscurity to one of India's top-15 AMCs in under five years, attracting both retail capital and scrutiny for its aggressive churn.